Pacholczyk T, Blakely RD, Amara SG (March 1991). „Expression cloning of a cocaine- and antidepressant-sensitive human noradrenaline transporter”. Nature350 (6316): 350–4. DOI:10.1038/350350a0. PMID2008212.
S. Schroeter, S. Apparsundaram, R. G. Wiley, L. H. Miner, S. R. Sesack & R. D. Blakely (May 2000). „Immunolocalization of the cocaine- and antidepressant-sensitive l-norepinephrine transporter”. The Journal of comparative neurology420 (2): 211–232. DOI:10.1002/(SICI)1096-9861(20000501)420:2<211::AID-CNE5>3.0.CO;2-3. PMID10753308.
Tellioglu T, Robertson D (November 2001). „Genetic or acquired deficits in the norepinephrine transporter: current understanding of clinical implications”. Expert Rev Mol Med2001 (29): 1–10. DOI:10.1017/S1462399401003878. PMID14987367.
nih.gov
ncbi.nlm.nih.gov
Pacholczyk T, Blakely RD, Amara SG (March 1991). „Expression cloning of a cocaine- and antidepressant-sensitive human noradrenaline transporter”. Nature350 (6316): 350–4. DOI:10.1038/350350a0. PMID2008212.
S. Schroeter, S. Apparsundaram, R. G. Wiley, L. H. Miner, S. R. Sesack & R. D. Blakely (May 2000). „Immunolocalization of the cocaine- and antidepressant-sensitive l-norepinephrine transporter”. The Journal of comparative neurology420 (2): 211–232. DOI:10.1002/(SICI)1096-9861(20000501)420:2<211::AID-CNE5>3.0.CO;2-3. PMID10753308.
Tellioglu T, Robertson D (November 2001). „Genetic or acquired deficits in the norepinephrine transporter: current understanding of clinical implications”. Expert Rev Mol Med2001 (29): 1–10. DOI:10.1017/S1462399401003878. PMID14987367.